MOTS-C vs 5-Amino-1MQ: Metabolic Peptides Compared

MOTS-C and 5-Amino-1MQ both enhance cellular metabolism but through completely different molecular targets. MOTS-C is a mitochondrial-derived peptide that activates AMPK (AMP-activated protein kinase) — the master metabolic sensor that increases glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. 5-Amino-1MQ inhibits NNMT (nicotinamide N-methyltransferase), an enzyme that when overexpressed promotes fat storage and reduces cellular energy expenditure. By blocking NNMT, 5-Amino-1MQ shifts metabolism toward energy expenditure rather than storage in test subjects. For research purposes only.

Target: MOTS-C = AMPK activation | 5-Amino-1MQ = NNMT inhibition Origin: MOTS-C = Mitochondrial genome | 5-Amino-1MQ = Synthetic small molecule Mechanism: MOTS-C = Increases energy expenditure via AMPK | 5-Amino-1MQ = Blocks fat storage enzyme Dose: MOTS-C = 200 mcg-2 mg daily | 5-Amino-1MQ = 2.5-5 mg daily Frequency: Both = Daily Vial sizes: MOTS-C = 5-40mg | 5-Amino-1MQ = 10mg, 50mg Reconstitution: Both = 2mL BAC water Exercise synergy: MOTS-C = Strong (mimics exercise signalling) | 5-Amino-1MQ = Moderate Mitochondrial effects: MOTS-C = Direct (biogenesis) | 5-Amino-1MQ = Indirect (NAD+ preservation) Research maturity: MOTS-C = Moderate | 5-Amino-1MQ = Early stage

Choose MOTS-C when: The research investigates AMPK-mediated metabolic enhancement, mitochondrial function and biogenesis are study endpoints, or the protocol examines exercise-mimetic effects at the cellular level in test subjects. Choose 5-Amino-1MQ when: The research targets NNMT as a metabolic regulator, the study investigates fat storage vs expenditure pathways, or the protocol examines NAD+ metabolism and its relationship to energy balance in test subjects. Both represent novel approaches to metabolic research beyond traditional appetite suppression or lipolysis. They can potentially be combined for multi-pathway metabolic enhancement research. For research purposes only.